| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 81.82B | 79.91B | 71.16B | 74.66B | 70.03B | 67.73B |
| Gross Profit | 75.02B | 74.87B | 69.53B | 75.26B | 69.14B | 60.18B |
| EBITDA | 19.12B | 23.97B | 19.94B | 16.43B | 18.52B | 12.86B |
| Net Income | 12.83B | 13.25B | 10.87B | 9.50B | 11.40B | 5.10B |
Balance Sheet | ||||||
| Total Assets | 6.55T | 6.43T | 6.44T | 6.22T | 7.04T | 6.71T |
| Cash, Cash Equivalents and Short-Term Investments | 950.29B | 854.99B | 797.79B | 821.65B | 1.72T | 1.67T |
| Total Debt | 416.94B | 410.99B | 469.00B | 340.56B | 2.08T | 1.82T |
| Total Liabilities | 6.30T | 6.19T | 6.20T | 5.99T | 6.79T | 6.46T |
| Stockholders Equity | 240.53B | 237.36B | 242.29B | 226.53B | 248.42B | 244.61B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 26.79B | -820.00M | -1.04T | 134.91B | 876.43B |
| Operating Cash Flow | 0.00 | 30.31B | 3.58B | -1.03T | 138.80B | 880.03B |
| Investing Cash Flow | 0.00 | -101.48B | -145.75B | 165.66B | -83.53B | -18.92B |
| Financing Cash Flow | 0.00 | 30.31B | 85.42B | -28.75B | -3.00B | -2.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥663.32B | 7.04 | 9.13% | 2.79% | 20.96% | 22.58% | |
69 Neutral | ¥757.14B | 10.93 | 7.97% | 3.48% | 6.65% | -4.35% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥186.07B | 9.94 | ― | 4.42% | 2.13% | -25.62% | |
66 Neutral | ¥343.93B | 14.65 | 3.46% | 3.04% | 10.31% | -40.64% | |
65 Neutral | ¥249.18B | 12.34 | ― | 2.30% | 19.39% | 7.07% | |
56 Neutral | ¥224.92B | 6.81 | 13.08% | 1.25% | 15.37% | 26.00% |